NASDAQ: CINGCingulate Inc Stock Ownership - Who owns Cingulate?
Insider buying vs selling
Have Cingulate Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Matthew Brams | EVP and Chief Medical Officer | 2026-02-06 | 1,946 | $5.04 | $9.81kBuy |
| Jennifer L. Callahan | SVP and CFO | 2026-02-06 | 4,864 | $5.04 | $24.51kBuy |
| Shane J. Schaffer | Chief Executive Officer | 2026-02-06 | 6,809 | $5.04 | $34.32kBuy |
| Peter J. Werth | Director | 2026-02-06 | 19,455 | $5.04 | $98.05kBuy |
CING insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CING insiders and whales buy or sell their stock.
CING Shareholders
What type of owners hold Cingulate Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Werth Family Investment Associates LLC | 41.41% | 2,798,320 | $16.48M | Insider |
| Fountainhead Shrugged LLC | 11.96% | 807,828 | $4.76M | Insider |
| Raul R. Silva | 6.91% | 467,232 | $2.75M | Insider |
| Craig S. Gilgallon | 2.88% | 194,846 | $1.15M | Insider |
| Gregg Wm Givens | 2.58% | 174,318 | $1.03M | Insider |
| Horn Louis G. Van | 2.32% | 156,606 | $922.41k | Insider |
| Vanguard Group Inc | 2.24% | 151,433 | $891.94k | Institution |
| Kestra Advisory Services LLC | 1.81% | 122,000 | $718.58k | Institution |
| Peter J. Werth | 1.74% | 117,541 | $692.32k | Insider |
| Patrick Joseph Gallagher | 1.01% | 68,358 | $402.63k | Insider |
CING vs Biotech Stocks
Cingulate Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.